Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» margetuximab
margetuximab
Here's Why MacroGenics Jumped 156.6% in the First Half of 2020
Motley Fool
Thu, 07/9/20 - 10:29 pm
Macrogenics
HER2+ breast cancer
margetuximab
FDA
Macrogenics scoops its ASCO bounce
EP Vantage
Fri, 05/8/20 - 10:20 am
ASCO 2020
Macrogenics
margetuximab
cancer
breast cancer
gastric cancer
MacroGenics' Metastatic Breast Cancer Drug Shows Survival Benefits in Phase III Trial
BioSpace
Wed, 10/23/19 - 02:59 pm
Macrogenics
metastatic HER2-positive breast cancer
margetuximab
breast cancer
clinical trials
ASCO 2019 – Macrogenics builds a case for margetuximab
EP Vantage
Wed, 06/5/19 - 09:37 am
Macrogenics
margetuximab
HER-2 postive breast cancer
Breast cancer survival data buoys Macrogenics and Puma
Biopharma Dive
Thu, 05/16/19 - 11:28 pm
Macrogenics
margetuximab
Puma Biotechnology
Nerlynx
breast cancer
ASCO 2019
May 15 ASCO Quick Takes: After-hours pop for Iovance, MacroGenics; plus Takeda, Amgen, Forty Seven
BioCentury
Wed, 05/15/19 - 11:52 pm
Iovance
LN-145
cervical cancer
Takeda
TAK-788
non-small cell lung cancer
Amgen
AMG-510
Macrogenics
margetuximab
HER2-positive metastatic breast cancer
Forty Seven
MacroGenics touts a PhIII win in a head-to-head with best-seller Herceptin for metastatic breast cancer
Endpoints
Wed, 02/6/19 - 09:48 am
Macrogenics
metastatic breast cancer
margetuximab
clinical trials